The burden of superficial cutaneous fungal infections (SCFIs) among outpatient visits in the United States is high and ...
Fungal infections are more common in patients with psoriasis who receive interleukin-17 inhibitors, are of older age at the time of biologic therapy initiation, and have diabetes. Patients with ...